
SERA Valuation
Sera Prognostics Inc
- Overview
- Forecast
- Valuation
- Earnings
SERA Relative Valuation
SERA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SERA is overvalued; if below, it's undervalued.
Historical Valuation
Sera Prognostics Inc (SERA) is now in the Fair zone, suggesting that its current forward PS ratio of 160.07 is considered Fairly compared with the five-year average of -4.50. The fair price of Sera Prognostics Inc (SERA) is between 1.69 to 3.21 according to relative valuation methord.
Relative Value
Fair Zone
1.69-3.21
Current Price:2.41
Fair
-2.83
PE
1Y
3Y
5Y
Trailing
Forward
0.55
EV/EBITDA
Sera Prognostics Inc. (SERA) has a current EV/EBITDA of 0.55. The 5-year average EV/EBITDA is -2.28. The thresholds are as follows: Strongly Undervalued below -9.90, Undervalued between -9.90 and -6.09, Fairly Valued between 1.52 and -6.09, Overvalued between 1.52 and 5.33, and Strongly Overvalued above 5.33. The current Forward EV/EBITDA of 0.55 falls within the Historic Trend Line -Fairly Valued range.
0.53
EV/EBIT
Sera Prognostics Inc. (SERA) has a current EV/EBIT of 0.53. The 5-year average EV/EBIT is -2.25. The thresholds are as follows: Strongly Undervalued below -9.97, Undervalued between -9.97 and -6.11, Fairly Valued between 1.61 and -6.11, Overvalued between 1.61 and 5.46, and Strongly Overvalued above 5.46. The current Forward EV/EBIT of 0.53 falls within the Historic Trend Line -Fairly Valued range.
160.07
PS
Sera Prognostics Inc. (SERA) has a current PS of 160.07. The 5-year average PS is 210.29. The thresholds are as follows: Strongly Undervalued below -299.10, Undervalued between -299.10 and -44.41, Fairly Valued between 464.98 and -44.41, Overvalued between 464.98 and 719.67, and Strongly Overvalued above 719.67. The current Forward PS of 160.07 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Sera Prognostics Inc. (SERA) has a current P/OCF of 0.00. The 5-year average P/OCF is -2.64. The thresholds are as follows: Strongly Undervalued below -11.45, Undervalued between -11.45 and -7.04, Fairly Valued between 1.77 and -7.04, Overvalued between 1.77 and 6.17, and Strongly Overvalued above 6.17. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Sera Prognostics Inc. (SERA) has a current P/FCF of 0.00. The 5-year average P/FCF is -1.39. The thresholds are as follows: Strongly Undervalued below -7.99, Undervalued between -7.99 and -4.69, Fairly Valued between 1.91 and -4.69, Overvalued between 1.91 and 5.21, and Strongly Overvalued above 5.21. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Sera Prognostics Inc (SERA) has a current Price-to-Book (P/B) ratio of 0.97. Compared to its 3-year average P/B ratio of 2.21 , the current P/B ratio is approximately -56.02% higher. Relative to its 5-year average P/B ratio of 1.85, the current P/B ratio is about -47.56% higher. Sera Prognostics Inc (SERA) has a Forward Free Cash Flow (FCF) yield of approximately -31.06%. Compared to its 3-year average FCF yield of -30.42%, the current FCF yield is approximately 2.09% lower. Relative to its 5-year average FCF yield of -30.35% , the current FCF yield is about 2.33% lower.
1.03
P/B
Median3y
2.21
Median5y
1.85
-31.06
FCF Yield
Median3y
-30.42
Median5y
-30.35
Competitors Valuation Multiple
The average P/S ratio for SERA's competitors is 44.17, providing a benchmark for relative valuation. Sera Prognostics Inc Corp (SERA) exhibits a P/S ratio of 160.07, which is 262.41% above the industry average. Given its robust revenue growth of -29.17%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SERA decreased by 66.99% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -34.60K to -47.33K.
The secondary factor is the Revenue Growth, contributed -29.17%to the performance.
Overall, the performance of SERA in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

SKIN
Beauty Health Co
2.210
USD
+6.76%

FINW
Finwise Bancorp
19.300
USD
+4.49%

SMID
Smith-Midland Corp
41.140
USD
+4.90%

ODV
Osisko Development Corp
2.610
USD
+1.16%

BLRX
BioLine RX Ltd
3.740
USD
+4.18%

GASS
StealthGas Inc
7.240
USD
+0.98%

FVCB
FVCBankcorp Inc
13.610
USD
+5.26%

FXNC
First National Corp
23.590
USD
+5.78%

DC
Dakota Gold Corp
4.050
USD
+3.58%

OVLY
Oak Valley Bancorp
28.490
USD
+3.34%
FAQ

Is Sera Prognostics Inc (SERA) currently overvalued or undervalued?
Sera Prognostics Inc (SERA) is now in the Fair zone, suggesting that its current forward PS ratio of 160.07 is considered Fairly compared with the five-year average of -4.50. The fair price of Sera Prognostics Inc (SERA) is between 1.69 to 3.21 according to relative valuation methord.

What is Sera Prognostics Inc (SERA) fair value?

How does SERA's valuation metrics compare to the industry average?

What is the current P/B ratio for Sera Prognostics Inc (SERA) as of Aug 23 2025?

What is the current FCF Yield for Sera Prognostics Inc (SERA) as of Aug 23 2025?

What is the current Forward P/E ratio for Sera Prognostics Inc (SERA) as of Aug 23 2025?
